Marketed in 45 countries across Europe, the Mediterranean basin, North Africa, and the Asia-Pacific region, Brufen is a globally distributed brand of ibuprofen, classified as a non-steroidal anti-inflammatory with analgesic and antipyretic properties. It is one of the more recognisable ibuprofen brands internationally, and travellers frequently encounter the name on pharmacy shelves outside their home country.
Ibuprofen is used for the relief of pain and fever in a wide range of settings — including dental pain, neuralgia, influenza-associated symptoms, and musculoskeletal pain — and is also prescribed in inflammatory joint conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The structured indication list further down this page details each registered use across the markets where Brufen is sold.
Because Brufen is registered in so many countries, the same brand often appears in destinations as varied as Australia, Egypt, France, Hong Kong, and the Czech Republic. Regulatory status differs from one market to another, however: in some jurisdictions ibuprofen products are available over the counter for short-term use, while in others — particularly at higher strengths or for chronic inflammatory indications — they remain prescription-only. Packaging, pack sizes, and even the Brufen brand name itself can shift between markets, with the same molecule sold under a number of alternative commercial names.
Other non-steroidal anti-inflammatory molecules circulate worldwide alongside ibuprofen, and a local pharmacist is well placed to identify regional options when a familiar brand cannot be found. Anyone taking Brufen regularly, especially for an inflammatory condition rather than occasional pain, should treat substitution and dose decisions as a matter for their own healthcare provider.
